iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/19889804/
Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;33(2):405-7.
doi: 10.2337/dc09-0544. Epub 2009 Nov 4.

Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans

Norbert Stefan  1 , Konstantinos Kantartzis, Nora Celebi, Harald Staiger, Jürgen Machann, Fritz Schick, Alexander Cegan, Michaela Elcnerova, Erwin Schleicher, Andreas Fritsche, Hans-Ulrich Häring
Affiliations

Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans

Norbert Stefan et al. Diabetes Care. 2010 Feb.

Abstract

Objective: We investigated whether palmitoleate, which prevents insulin resistance in mice, predicts insulin sensitivity in humans.

Research design and methods: The fasting fatty acid pattern in the plasma free fatty acid (FFA) fraction was determined in 100 subjects at increased risk for type 2 diabetes. Insulin sensitivity was estimated during an oral glucose tolerance test (OGTT) at baseline and after 9 months of lifestyle intervention and measured during the euglycemic-hyperinsulinemic clamp (n = 79).

Results: Circulating palmitoleate (OGTT:F ratio = 8.2, P = 0.005; clamp:F ratio = 7.8, P = 0.007) but not total FFAs (OGTT:F ratio = 0.6, P = 0.42; clamp:F ratio = 0.7, P = 0.40) correlated positively with insulin sensitivity, independently of age, sex, and adiposity. High baseline palmitoleate predicted a larger increase in insulin sensitivity. For 1-SD increase in palmitoleate, the odds ratio for being in the highest versus the lowest tertile of adjusted change in insulin sensitivity was 2.35 (95% CI 1.16-5.35).

Conclusions: Circulating palmitoleate strongly and independently predicts insulin sensitivity, suggesting that it plays an important role in the pathophysiology of insulin resistance in humans.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cross-sectional relationships of circulating palmitoleate with insulin sensitivity estimated from the OGTT (A) and measured by the clamp (B) at baseline. Insulin sensitivity was adjusted for age, sex, and body fat in multivariate linear regression models (regression line and 95% CI). arb. units, arbitrary units.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009; 48: 44– 51 - PMC - PubMed
    1. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007; 87: 507– 520 - PMC - PubMed
    1. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015– 3025 - PMC - PubMed
    1. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999; 48: 1600– 1606 - PubMed
    1. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609– 1616 - PubMed

Publication types

MeSH terms